Tetralogic (TLOG) PT Cut to $7 at Needham & Company After Halting Study; Maintains 'Buy'
Tweet Send to a Friend
Needham & Company analyst Chad Messer cut his price target on Tetralogic Pharmaceuticals (NASDAQ: TLOG) to $7.00 (from $10.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
